Last Price
0.046
Today's Change
-0.006 (11.53%)
Day's Change
0.04 - 0.055
Trading Volume
920,321
Market Cap
2 Million
Shares Outstanding
43 Million
Avg Volume
3,789,504
Avg Price (50 Days)
0.23
Avg Price (200 Days)
0.81
PE Ratio
0.00
EPS
-94.13
Earnings Announcement
21-Feb-2024
Previous Close
0.05
Open
0.05
Day's Range
0.04 - 0.055
Year Range
0.04 - 7.64
Trading Volume
920,321
1 Day Change
-11.54%
5 Day Change
-24.59%
1 Month Change
-70.32%
3 Month Change
-89.71%
6 Month Change
-91.14%
Ytd Change
-98.67%
1 Year Change
-99.17%
3 Year Change
-100.00%
5 Year Change
-100.00%
10 Year Change
-100.00%
Max Change
-100.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.